Inventor
HIGGINS DEBORAH L
US21 patents
⚠️ This page may combine multiple inventors who share the name “HIGGINS DEBORAH L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
20 patentsUS5262170ANov 16, 1993
Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
GENENTECH INC22 citations96
US5108901AApr 28, 1992
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC38 citations92
US4935237AJun 19, 1990
Processes for the preparation of t-PA mutants
GENENTECH INC33 citations92
US5770426AJun 23, 1998
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC7 citations82
US5616486AApr 1, 1997
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC13 citations82
US5520913AMay 28, 1996
Tissue plasminogen activator having zymogenic properties
GENENTECH INC13 citations82
US5411871AMay 2, 1995
Method for identifying tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC10 citations82
US5405771AApr 11, 1995
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC12 citations82
US5094953AMar 10, 1992
Human tissue plasminogen activator variants
GENENTECH INC14 citations80
US5840564ANov 24, 1998
Tussue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC4 citations74
US5714145AFeb 3, 1998
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC12 citations74
US5770425AJun 23, 1998
Human tissue plasminogen activator variants
GENENTECH INC8 citations71
US5314818AMay 24, 1994
Human tissue plasminogen activator variants
GENENTECH INC6 citations71
US5190756AMar 2, 1993
Methods and materials for expression of human plasminogen variant
GENENTECH INC10 citations71
US5087572AFeb 11, 1992
Dna encoding human plasminogen modified at the cleavage site
GENENTECH INC14 citations71
US5728567AMar 17, 1998
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC1 citations63
US5614190AMar 25, 1997
Tissue plasminogen activator having zymogenic or fibrin specific properties
GENENTECH INC1 citations63
US5037646AAug 6, 1991
Processes for the treatment of vascular disease
GENENTECH INC6 citations62
US5366886ANov 22, 1994
Human tissue plasminogen activator variant
GENENTECH INC1 citations60
US5821105AOct 13, 1998
Tissue plasminogen activator having zymognic or fibrin specific properties
GENENTECH INC0 citations52